Latest Insider Transactions at Orthopediatrics Corp (KIDS)
This section provides a real-time view of insider transactions for Orthopediatrics Corp (KIDS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ORTHOPEDIATRICS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ORTHOPEDIATRICS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
Terry D Schlotterback Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+9.88%
|
-
|
|
Jun 14
2023
|
Samuel D Riccitelli Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+17.51%
|
-
|
|
Apr 27
2023
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
3,333
-3.85%
|
$166,650
$50.1 P/Share
|
|
Apr 25
2023
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
828
-0.95%
|
$41,400
$50.02 P/Share
|
|
Apr 21
2023
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
644
-0.73%
|
$32,200
$50.02 P/Share
|
|
Mar 15
2023
|
Daniel J Gerritzen General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
19,617
+26.24%
|
-
|
|
Mar 15
2023
|
David R Bailey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,444
+23.47%
|
-
|
|
Mar 15
2023
|
Fred Hite COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+22.79%
|
-
|
|
Mar 15
2023
|
Mark C Throdahl Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,266
+8.04%
|
-
|
|
Mar 15
2023
|
Gregory A Odle President of Scoliosis |
BUY
Grant, award, or other acquisition
|
Direct |
19,617
+18.22%
|
-
|
|
Mar 15
2023
|
Joseph W Hauser Pres. Trauma & Def. Correction |
BUY
Grant, award, or other acquisition
|
Direct |
19,617
+26.02%
|
-
|
|
Mar 06
2023
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
3,421
-4.76%
|
$150,524
$44.03 P/Share
|
|
Mar 06
2023
|
Fred Hite COO and CFO |
SELL
Open market or private sale
|
Direct |
4,099
-5.41%
|
$176,257
$43.77 P/Share
|
|
Mar 06
2023
|
David R Bailey President and CEO |
SELL
Open market or private sale
|
Direct |
4,052
-3.88%
|
$178,288
$44.4 P/Share
|
|
Mar 06
2023
|
Daniel J Gerritzen General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
3,315
-8.53%
|
$145,860
$44.62 P/Share
|
|
Mar 06
2023
|
Mark C Throdahl Director |
SELL
Open market or private sale
|
Direct |
4,515
-3.41%
|
$194,145
$43.83 P/Share
|
|
Mar 02
2023
|
Joseph W Hauser Pres. Trauma & Def. Correction |
SELL
Open market or private sale
|
Direct |
2,554
-6.6%
|
$109,822
$43.74 P/Share
|
|
Feb 02
2023
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
1,195
-1.64%
|
$59,750
$50.0 P/Share
|
|
Jan 20
2023
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
80
-0.11%
|
$3,760
$47.0 P/Share
|
|
Jan 13
2023
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
1,771
-2.36%
|
$79,695
$45.0 P/Share
|
|
Jan 09
2023
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
229
-0.3%
|
$10,305
$45.04 P/Share
|
|
Sep 20
2022
|
Squadron Capital LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1,525,000
+18.1%
|
-
|
|
Sep 20
2022
|
David R Pelizzon Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,525,000
+18.1%
|
-
|
|
Sep 20
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,525,000
+18.1%
|
-
|
|
Aug 15
2022
|
Terry D Schlotterback Director |
SELL
Payment of exercise price or tax liability
|
Direct |
373
-2.28%
|
-
|
|
Aug 15
2022
|
Terry D Schlotterback Director |
BUY
Exercise of conversion of derivative security
|
Direct |
670
+3.94%
|
-
|
|
Jun 16
2022
|
Harold Ruf Director |
BUY
Open market or private purchase
|
Indirect |
1,235
+8.2%
|
$48,165
$39.45 P/Share
|
|
Jun 07
2022
|
Harold Ruf Director |
BUY
Bona fide gift
|
Indirect |
1,595
+8.62%
|
-
|
|
Jun 07
2022
|
Harold Ruf Director |
SELL
Bona fide gift
|
Direct |
1,595
-25.21%
|
-
|
|
Jun 01
2022
|
Stephen F Burns Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,691
+18.83%
|
-
|
|
Jun 01
2022
|
Samuel D Riccitelli Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,691
+18.83%
|
-
|
|
Jun 01
2022
|
Terry D Schlotterback Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,691
+9.75%
|
-
|
|
Jun 01
2022
|
Kevin Unger Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,691
+18.83%
|
-
|
|
Jun 01
2022
|
(Reynolds) Marie C Infante Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,691
+20.31%
|
-
|
|
Jun 01
2022
|
David R Pelizzon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,691
+6.38%
|
-
|
|
Jun 01
2022
|
Bryan W Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,691
+17.28%
|
-
|
|
Jun 01
2022
|
Harold Ruf Director |
BUY
Bona fide gift
|
Indirect |
1,400
+10.01%
|
-
|
|
Jun 01
2022
|
Harold Ruf Director |
SELL
Bona fide gift
|
Direct |
1,400
-31.17%
|
-
|
|
Jun 01
2022
|
Harold Ruf Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,691
+27.35%
|
-
|
|
May 16
2022
|
Harold Ruf Director |
BUY
Other acquisition or disposition
|
Indirect |
5,990
+34.87%
|
-
|
|
May 16
2022
|
Harold Ruf Director |
SELL
Other acquisition or disposition
|
Indirect |
11,980
-69.74%
|
-
|
|
Mar 15
2022
|
Fred Hite COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
14,836
+16.38%
|
-
|
|
Mar 15
2022
|
Daniel J Gerritzen General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+23.6%
|
-
|
|
Mar 15
2022
|
Joseph W Hauser Pres. Trauma & Def. Correction |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+23.67%
|
-
|
|
Mar 15
2022
|
Mark C Throdahl Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,363
+7.22%
|
-
|
|
Mar 15
2022
|
Gregory A Odle President of Scoliosis |
BUY
Grant, award, or other acquisition
|
Direct |
12,364
+14.13%
|
-
|
|
Mar 15
2022
|
David R Bailey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+12.51%
|
-
|
|
Mar 02
2022
|
David R Bailey President and CEO |
SELL
Open market or private sale
|
Direct |
4,078
-4.32%
|
$236,524
$58.1 P/Share
|
|
Mar 02
2022
|
Daniel J Gerritzen General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
3,918
-12.74%
|
$227,244
$58.46 P/Share
|
|
Mar 02
2022
|
Fred Hite COO and CFO |
SELL
Open market or private sale
|
Direct |
4,919
-7.48%
|
$280,383
$57.48 P/Share
|